Loading
A phase 3 trial of cisplatin and durvalumab in lung cancer, run by National Cancer Center Hospital East, not yet recruiting.
Efficacy and Safety of CRT, Durvalumab and Surgery for SST is a phase 3, interventional study registered as NCT04465968 by National Cancer Center Hospital East, with a registry enrolment figure of 84 participants, started 2020-09-01 and due to reach its primary completion in 2027-08-31. Interventions recorded: Cisplatin; S1; concurrent radiotherapy; Durvalumab; Surgery; Durvalumab. Conditions listed: Superior Sulcus Tumor; Non-small Cell Lung Cancer Stage IIB; Non Small Cell Lung Cancer Stage III. Primary outcome: 3-year overall survival rate (3y-OS). Lung eligibility wording from the registry: "A definite diagnosis of non-small cell lung cancer has been obtained by biopsy from the primary lesion". No results are recorded here; the registry entry is the source.
Shares Durvalumab, Lung cancer trials open today (registry snapshot), AstraZeneca, Cisplatin and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Durvalumab, Lung cancer trials open today (registry snapshot), Cisplatin and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Durvalumab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Durvalumab, Lung cancer trials open today (registry snapshot), Cisplatin, Platinum agents and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Cisplatin, Platinum agents and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Platinum agents, Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Platinum agents, Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Cisplatin, Platinum agents, Cytotoxic chemotherapy and the tag lung-deep-dive.